4,7,10,13-eicosatetraynoic acid has been researched along with phenidone in 1 studies
Studies (4,7,10,13-eicosatetraynoic acid) | Trials (4,7,10,13-eicosatetraynoic acid) | Recent Studies (post-2010) (4,7,10,13-eicosatetraynoic acid) | Studies (phenidone) | Trials (phenidone) | Recent Studies (post-2010) (phenidone) |
---|---|---|---|---|---|
11 | 0 | 0 | 184 | 0 | 11 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kishore, NP; Rao, GH; White, JG | 1 |
1 other study(ies) available for 4,7,10,13-eicosatetraynoic acid and phenidone
Article | Year |
---|---|
Differential effects of putative inhibitors on cytosolic and membrane associated platelet lipoxygenase.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; 5,8,11,14-Eicosatetraynoic Acid; Adult; Arachidonate Lipoxygenases; Blood Platelets; Cell Membrane; Cytosol; Humans; Indomethacin; Lipoxygenase Inhibitors; Masoprocol; Prostaglandin Antagonists; Pyrazoles; Quercetin; Substrate Specificity; Umbelliferones | 1987 |